The 1.1 Å crystal structure of human TGF-β type II receptor ligand binding domain

被引：47
|
作者：
Boesen, CC
Radaev, S
Motyka, SA
Patamawenu, A
Sun, PD [1 ]
机构：
[1] NIAID, Immunogenet Lab, Struct Biol Sect, NIH, Rockville, MD 20852 USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA
来源：
STRUCTURE | 2002年 / 10卷 / 07期
关键词：
D O I：
10.1016/S0969-2126(02)00780-3
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Transforming growth factor beta (TGF-beta) is involved in a wide range of biological functions including development, carcinogenesis, and immune regulation. Here we report the 1.1 Angstrom resolution crystal structure of human TGF-beta type II receptor ectodomain (TBRII). The overall structure of TBRII is similar to that of activin type II receptor ectodomain (ActRII) and bone morphogenic protein receptor type IA (BRIA). It displays a three-finger toxin fold with fingers formed by the beta strand pairs beta1-beta2, beta3-beta4, and beta5-beta6. The first finger in the TBRII is significantly longer than in ActRII and BRIA and folds tightly between the second finger and the C terminus. Surface charge distributions and hydrophobic patches predict potential TBRII binding sites.
引用
收藏
页码：913 / 919
页数：7
相关论文
共 50 条
  • [31] Microglia-derived TGF-β as an important regulator of glioblastoma invasion -: an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor
    Wesolowska, A.
    Kwiatkowska, A.
    Slomnicki, L.
    Dembinski, M.
    Master, A.
    Sliwa, M.
    Franciszkiewicz, K.
    Chouaib, S.
    Kaminska, B.
    ONCOGENE, 2008, 27 (07) : 918 - 930
  • [32] Microglia-derived TGF-β as an important regulator of glioblastoma invasion—an inhibition of TGF-β-dependent effects by shRNA against human TGF-β type II receptor
    A Wesolowska
    A Kwiatkowska
    L Slomnicki
    M Dembinski
    A Master
    M Sliwa
    K Franciszkiewicz
    S Chouaib
    B Kaminska
    Oncogene, 2008, 27 : 918 - 930
  • [33] Crystal Structure of the Vitamin D Receptor Ligand-Binding Domain with Lithocholic Acids
    Ikura, Teikichi
    Ito, Nobutoshi
    VITAMIN D HORMONE, 2016, 100 : 117 - 136
  • [34] Structure and dynamics of differential ligand binding in the human ρ-type GABAA receptor
    Cowgill, John
    Fan, Chen
    Haloi, Nandan
    Tobiasson, Victor
    Zhuang, Yuxuan
    Howard, Rebecca J.
    Lindahl, Erik
    NEURON, 2023, 111 (21) : 3450 - +
  • [35] Crystal structure of the ligand binding suppressor domain of type 1 inositol 1,4,5-trisphosphate receptor
    Bosanac, I
    Yamazaki, H
    Matsu-ura, T
    Michikawa, T
    Mikoshiba, K
    Ikura, M
    MOLECULAR CELL, 2005, 17 (02) : 193 - 203
  • [36] Roles for the type III TGF-β receptor in human cancer
    Gatza, Catherine E.
    Oh, Sun Young
    Blobe, Gerard C.
    CELLULAR SIGNALLING, 2010, 22 (08) : 1163 - 1174
  • [37] Immunohistochemical localization of TGF-β type II receptor and TGF-β3 during palatogenesis in vivo and in vitro
    Cui, XM
    Warburton, D
    Zhao, JS
    Crowe, DL
    Shuler, CF
    INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY, 1998, 42 (06): : 817 - 820
  • [38] KSHV LANA inhibits TGF-β signaling through epigenetic silencing of the TGF-β type II receptor
    Di Bartolo, Daniel L.
    Cannon, Mark
    Liu, Yi-Fang
    Renne, Rolf
    Chadburn, Amy
    Boshoff, Chris
    Cesarman, Ethel
    BLOOD, 2008, 111 (09) : 4731 - 4740
  • [39] A MOUSE TGF-BETA TYPE-I RECEPTOR THAT REQUIRES TYPE-II RECEPTOR FOR LIGAND-BINDING
    SUZUKI, A
    SHIODA, N
    MAEDA, T
    TADA, M
    UENO, N
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1994, 198 (03) : 1063 - 1069
  • [40] Structure and function of the glucocorticoid receptor ligand binding domain
    Bledsoe, RK
    Stewart, EL
    Pearce, KH
    NUCLEAR RECEPTOR COREGULATORS, 2004, 68 : 49 - 91
12345